
A single diagnostic test for the virus causing Covid-19 infections and three other respiratory diseases received clearance for marketing in Europe. . . . → Read More: Diagnostic Cleared for Covid-19, Other Diseases
|
|||||
![]() A single diagnostic test for the virus causing Covid-19 infections and three other respiratory diseases received clearance for marketing in Europe. . . . → Read More: Diagnostic Cleared for Covid-19, Other Diseases ![]() A clinical trial shows homes installed with devices that attract then kill mosquitos have fewer malaria cases than homes with standard preventions. . . . → Read More: Trial Shows Home Mosquito Device Cuts Malaria Cases ![]() Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations. . . . → Read More: New Trial Testing Reformulated Covid-19 Vaccine ![]() Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease. . . . → Read More: Novartis, Gates Partner on Sickle Cell Gene Therapy ![]() Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine ![]() A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines ![]() A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal ![]() Interim results from a clinical trial in Russia of a two-dose vaccine show a high efficacy rate in preventing Covid-19 disease and few serious adverse effects. . . . → Read More: Covid-19 Vaccine Shown Safe, Effective in Russian Test ![]() Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network ![]() A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round. . . . → Read More: Food Allergy Biotech Raises $40M in New Funds |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |